Clinical Considerations for the Management of Androgen Indifferent Prostate Cancer

BACKGROUND: Many systemic therapies for advanced prostate cancer work by disrupting androgen receptor signaling. Androgen indifferent prostate cancer (AIPC) variants, including aggressive variant prostate cancer (AVPC), neuroendocrine prostate cancer (NEPC), and double negative prostate cancer (DNPC...

Descripción completa

Detalles Bibliográficos
Autores principales: Berchuck, Jacob E., Viscuse, Paul V., Beltran, Himisha, Aparicio, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353003/
https://www.ncbi.nlm.nih.gov/pubmed/33568748
http://dx.doi.org/10.1038/s41391-021-00332-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353003/
https://www.ncbi.nlm.nih.gov/pubmed/33568748
http://dx.doi.org/10.1038/s41391-021-00332-5

Ejemplares similares